Riskpilot← Back to searchSign inGet full accessEbne Medical AB
ABActiveOrg 5567124333Teknologgatan 8 BMedical specialists activities · NACE 8622Est. 20060 employees
Revenue 2024
SEK 1,7M
+17% vs 2023
EBITDA margin
83.1%
+6% vs 2023
Equity ratio
52.8%
Financial strength
Net profit 2024
SEK 812K
+3% vs 2023
| Revenue | SEK 1,7M | +17% |
| EBITDA | SEK 1,4M | +6% |
| Net profit | SEK 812K | +3% |
| Total assets | SEK 4,9M | +32% |
| Equity | SEK 2,6M | +46% |
| Employees | 0 | — |
Legal name
Ebne Medical AB
Org number
5567124333
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 oktober 2006
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva läkarbemanning, hälsorådgivning samt medicinsk kompetens, även handel med värdepapper samt därmed förenlig verksamhet.
Address
Teknologgatan 8 B
Phone
+46704261470
Email
mahin_nezafat@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 802 | 1 538 | 1 532 | 1 451 | 1 692 |
| Staff expenses | — | — | −0 | −24 | 11 |
| EBITDA | 1 008 | 1 008 | 1 370 | 1 324 | 1 407 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 008 | 1 008 | 1 370 | 1 324 | 1 407 |
| Net financials | — | — | −2 | 25 | 34 |
| Profit before tax | 718 | 842 | 1 208 | 1 005 | 1 070 |
| Tax | −187 | −194 | −255 | −215 | −258 |
| Net profit | 531 | 648 | 953 | 790 | 812 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 737 | 3 441 | 2 810 | 3 703 | 4 904 |
| Equity | 1 235 | 1 882 | 1 135 | 1 775 | 2 587 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 643 | 533 | 489 | 397 | 415 |
| Total debt | 643 | 533 | 489 | 397 | 415 |
EBITDA margin
83.1%
This company
15.8%
Market median
+426% vs market
20202024
Equity ratio
52.8%
This company
38.2%
Market median
+38% vs market
20202024
Return on equity
31.4%
This company
18.4%
Market median
+71% vs market
20202024
Net profit margin
48.0%
This company
8.1%
Market median
+493% vs market
20202024
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20202024
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ebne Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mahin Nezafat | Chairman | 0 companies |
| Mojtaba Mobargha | Board of Directors | 0 companies |
| Anahita Mobargha Essman | Deputy Board Member | 0 companies |
| Nathalie Sadaf Mobargha | Deputy Board Member | 0 companies |